Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Intravenous Immunoglobulin Companies

Intravenous Immunoglobulin (IVIG) is a medical product made from pooled human plasma containing antibodies that can be used to treat various medical conditions, primarily those related to the immune system. IVIG is administered intravenously and is used to boost the immune system, treat autoimmune disorders, and provide passive immunity.

Intravenous Immunoglobulin Key Companies

Latest Intravenous Immunoglobulin Companies Update

Biotest AG receives EU approval for Yimmugo (IgG Next Generation) sugar-free, ready-to-use solution offers a new IVIG option for primary antibody deficiency syndromes, secondary immune deficiency, and immunomodulation in autoimmune diseases.

Takeda launches Hizentra Plus new formulation combines Hizentra (immune globulin intravenous, human) with hyaluronidase for subcutaneous administration, providing an alternative delivery option for patients with needle phobia or venous access challenges.

CSL Behring expands its portfolio with Cuvitru FDA-approved subcutaneous IVIG option offers another potential avenue for convenient and flexible administration, improving patient compliance and quality of life.

Companies like Octapharma and Grifols are developing and expanding their pediatric IVIG offerings, addressing the specific requirements and safety considerations for younger patients.

List of Intravenous Immunoglobulin Key Companies in the Market

Kedrion S.p.A

Baxter International Inc

OMRIX Biopharmaceuticals Ltd

Biotest AG

Hualan Biological Engineering Inc

Shanghai RAAS Blood Products Co

CSL Limited

Grifols

Guizhou Taibang Biological Products Co

Intravenous Immunoglobulin Market Highlights:

Intravenous Immunoglobulin Market Size

Intravenous Immunoglobulin Market Trends

Intravenous Immunoglobulin Market Analysis

Intravenous Immunoglobulin Market Share

Intravenous Immunoglobulin Market Highlights:

Intravenous Immunoglobulin Market Trends

Intravenous Immunoglobulin Market Analysis

Intravenous Immunoglobulin Market Share

Intravenous Immunoglobulin Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.